Skip to main content
Brainsway Ltd. logo

Brainsway Ltd. — Investor Relations & Filings

Ticker · BWAY ISIN · IL0011007189 TA Manufacturing
Filings indexed 383 across all filing types
Latest filing 2026-05-21 Director's Dealing
Country IL Israel
Listing TA BWAY

About Brainsway Ltd.

https://www.brainsway.com/

Brainsway Ltd. is a medical technology company focused on developing and marketing advanced noninvasive neurostimulation treatments for mental health and addictive disorders. The company's core product is its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) system, which uses a patented H-coil to stimulate deeper and broader regions of the brain. The technology is designed as a safe and effective non-drug treatment option. The Deep TMS system has received multiple FDA clearances for conditions including Major Depressive Disorder (MDD), anxious depression, and Obsessive-Compulsive Disorder (OCD), for which it was the first noninvasive medical device to receive such clearance. It is also FDA-cleared as an aid for short-term smoking cessation, the first TMS device to be cleared for an addiction indication.

Recent filings

Filing Released Lang Actions
Other Report or Announcement
Director's Dealing Classification · 95% confidence The document is an SEC Form 4 “Statement of Changes in Beneficial Ownership” filed under Section 16 of the Securities Exchange Act of 1934, detailing the insider transactions by a company director (issuance and disposition of ordinary shares and options). This is a personal share transaction report by a director and thus falls under Director's Dealing.
2026-05-21 English
Other Report or Announcement
Director's Dealing Classification · 80% confidence The document is an Israeli MAGNA filing indicating an attached Form 4 insider trading report (“report on Form 4 Ety Mitrany May 21, 2026”). Form 4 is used for director/executive share transactions. Although the notice itself is brief and attaches the actual form, it clearly pertains to insider share dealings. Therefore, this should be classified as Director’s Dealing (DIRS).
2026-05-21 English
BrainsWay Announces Minority-Stake Investment in Hopemark Health
Regulatory Filings Classification · 85% confidence The document is an SEC Form 6-K filing by BrainsWay Ltd., which is a periodic report by a foreign private issuer. It incorporates an exhibit consisting of a press release announcing a minority‐stake investment. Form 6-K filings fall under general regulatory filings rather than a specific quarterly/annual report, earnings release, or capital market transaction report category (the investment announcement is embedded but the container document is a 6-K). Therefore, it is classified as Regulatory Filings (RNS).
2026-05-18 English
BrainsWay Announces Minority-Stake Investment in Hopemark Health
Report Publication Announcement Classification · 85% confidence The document is a short immediate report filed under Israeli Securities Regulations notifying of a forthcoming report and attaching the PDF (‘BrainsWay_Announces_Investment_in_Hopemark_isa.pdf’) rather than providing substantive financial or operational details itself. Under the “menu vs meal” rule, this is a report publication announcement (not the report content), so it should be classified as RPA.
2026-05-18 English
Immediate Report
Investor Presentation Classification · 87% confidence The filing is a Form 6-K submitted by a foreign private issuer that includes “Exhibit 99.1 – Investor Deck.” The bulk of the text is a detailed slide presentation with financial highlights, strategy, market positioning, and guidance—consistent with an investor presentation. Therefore, the document should be classified as Investor Presentation (IP).
2026-05-13 English
Immediate Report
Report Publication Announcement Classification · 85% confidence The document is an Immediate Report filed via the Israeli MAGNA system. It is very short (≈1,900 characters) and solely announces that the ‘BrainsWay May 2026 Corporate Presentation’ PDF is attached. It does not contain the actual presentation or substantive financial data, so per the “menu vs meal” rule it is a Report Publication Announcement rather than the report itself.
2026-05-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.